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Abstract
Background: Appropriate antibiotic use in patients with complicated urinary tract infections can be measured by a
valid set of nine quality indicators (QIs). We evaluated the performance of these QIs in a national setting and
investigated which determinants influenced appropriate antibiotic use. For the latter, we distinguished patient,
department and hospital characteristics, including organizational interventions aimed at improving the quality
of antibiotic use (antibiotic stewardship elements).
Methods: A retrospective, observational multicentre study included 1964 patients (58 % male sex) with a
complicated urinary tract infection treated at Internal Medicine and Urology departments of 19 Dutch university and
non-university hospitals. Data of 50 patients per department were extracted from medical charts. QI performance scores
were calculated using previously constructed algorithms. Department and hospital characteristics were collected using
questionnaires filled in by an internal medicine physician and an urologist. Regression analysis was performed to identify
determinants of QI performance. Clustering at department and hospital level was taken into account through inclusion
of random effects in a multi-level model.
Results: Median QI performance of departments varied between 31 % (‘Treat urinary tract infection in men according to
local guideline’) and 77 % (‘Perform urine culture’). The patient characteristics non-febrile urinary tract infection, female
sex and presence of a urinary catheter were negatively associated with performance on many QIs. The presence of an
infectious diseases physician and an antibiotic formulary were positively associated with ‘Prescribe empirical therapy
according to guideline’. No other department or hospital characteristics, including stewardship elements, were
consistently associated with better QI performance.
Conclusions: A large inter-department variation was demonstrated in the appropriateness of antibiotic use. In particular
certain patient characteristics (more than department or hospital characteristics) influenced the quality of antibiotic use.
Some, but not all antibiotic stewardship elements did translate into better QI performance.
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Background
Appropriate antibiotic use in patients with infections is
important for optimal clinical outcome, to avoid prevent-
able complications such as renal failure and Clostridium
difficile infection, to control the growth of antibiotic resist-
ance and to contain costs [1–3].
However, according to medical literature, up to 50 % of
hospital antibiotic use is inappropriate [4, 5], and Anti-
biotic Stewardship Programs have been recommended to
improve appropriate antibiotic use [6]. They can be consid-
ered as a menu of interventions that can be designed and
adapted to fit the infrastructure of any hospital [7]. How-
ever, to successfully design effective and targeted interven-
tions to improve antibiotic prescribing, it is first necessary
to better understand the factors that influence appropriate
prescribing [8, 9]. Various determinants are known to be of
influence, resulting in large differences in appropriate anti-
biotic use between hospitals [10].
Urinary Tract Infections (UTIs) are among the most
prevalent infectious diseases in the in- and outpatient
setting, being a major cause of morbidity and mortality,
and resulting in many hospitalizations [11]. Appropriate
antibiotic use for patients with a complicated UTI was pre-
viously defined with a valid set of nine guideline-based
quality indicators [12]. The objective of the current study
was to assess in a large group of hospitals the perform-
ance on these nine quality indicators and to identify
which determinants influenced appropriate antibiotic
use. For the latter, we distinguished patient, department
and hospital characteristics, including organizational in-
terventions aimed at improving the quality of antibiotic
use (stewardship elements).
Methods
Setting and population
Our study presents the baseline results of a cluster ran-
domized controlled trial testing a multifaceted stewardship
program to improve the appropriateness of antibiotic
use in patients with a complicated UTI in hospitals
(http://www.trialregister.nl; NTR1742).
Appropriateness of antibiotic use in patients with a
complicated UTI was assessed at the internal medicine
and urology departments of 19 university, teaching and
non-teaching hospitals located throughout the Netherlands.
Included were adult (≥16 years) inpatients/outpatients di-
agnosed in 2008 by an internist or a urologist with a com-
plicated UTI as main diagnosis, and treated as such. We
defined a complicated UTI as a UTI with one (or more) of
the following characteristics: male gender, pregnancy, any
functional or anatomical abnormality of the urinary tract,
immunocompromising disease or medication, or a UTI
with symptoms of tissue invasion or systemic infection
[13]. The identification of patients as performed using the
national diagnosis registration system. Subsequent manual
screening took place, with the use of medical and nursing
records and admission sheets. A minimum number of 50
patients per department was included. If required to reach
a sufficient number also patients from 2007 were included.
Excluded were patient groups for whom the Dutch national
guideline does not provide a treatment recommendation
(i.e. patients with a nephrostomy) and patients who were
currently being treated for another infection or had been
transferred from or to another hospital.
The medical ethical committee of the Academic Med-
ical Centre Amsterdam considered our study and con-
cluded that it was deemed exempt from their approval
(ref 08.17.1775). No informed consent was obtained from
patients because no interventions at the patient level were
done and patient data were analysed in a retrospect-
ive design anonymously, for the aim to improve qual-
ity or healthcare.
Variables and data collection
Quality indicators for complicated UTI care (dependent
variables)
Between February and November 2009 the study researcher
(VS) and a trained research assistant retrospectively col-
lected data from medical and nursing charts, admission
sheets, medication charts, and laboratory and culture re-
sults. The appropriateness of antibiotic use was scored
using quality indicators (QIs) based on the treatment rec-
ommendations from the Dutch national guideline for the
antibiotic treatment of complicated UTIs [14]. A 3-step
modified Delphi approach among experts was used to sys-
tematically develop a set of nine QIs, which was subse-
quently validated [15] (Table 1). The evidence-based Dutch
guideline comprises a general treatment recommendation
for patients with complicated UTIs, as well as recommen-
dations for subpopulations with special conditions, e.g.
patients with a urinary catheter and men with chronic
prostatitis. All subpopulations were included in each QI
and evaluated by their own treatment recommendation.
Men with a UTI scored also on an additional QI (‘Treat
UTI in men according to the guideline’). This QI applies to
(denominator) all men with a UTI, including those with a
chronic prostatitis, but except those with a urinary catheter.
It evaluates (numerator) whether they were treated in ac-
cordance with the guideline regarding the empirical ther-
apy and treatment duration for complicated UTIs and, in
case of a chronic prostatitis, whether they were treated with
culture-guided therapy for the recommended duration.
Although local hospital antibiotic treatment guidelines
are usually based on the national guideline [14], they can
differ, e.g. because of local resistance patterns. Therefore,
the QIs concerning prescribing empirical therapy, dur-
ation of treatment and treatment of men were scored ac-
cording to the national guideline as well as according to
the local guideline if available.
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Previously constructed algorithms, in which data dir-
ectly originating from the patient chart had to be inserted,
were used to calculate the scores for each of the QIs.
Determinants at the patient-, department- and hospital
level (independent variables)
Based on prior research findings the following poten-
tially relevant patient, department and hospital charac-
teristics were selected (Tables 2, 3 and 4) [9, 10, 16–20].
Patient characteristics (Table 2) included 14 variables
containing demographic data (age, sex), comorbidities and
other characteristics. Comorbidity was defined as hav-
ing one or more of the following diseases: cardiovascular
disease, immunocompromising disease, diabetes mellitus,
urological comorbidity, and kidney disease. Urological co-
morbidity included an anatomical abnormality of the urin-
ary tract (excluding benign prostatic hyperplasia), a history
of urolithiasis, or neurological urinary retention.
UTI was classified as ‘febrile UTI’ or ‘non-febrile UTI’.
A febrile UTI included pyelonephritis, urosepsis, acute
prostatitis and UTI with systemic symptoms (fever, haemo-
dynamic instability or delirium, as described by the attend-
ing physician). Non-febrile UTIs were a cystitis/chronic
prostatitis in men, UTIs without systemic symptoms in
catheterized patients, and cystitis in diabetic or immuno-
compromised women. A urine culture result was consid-
ered ‘positive’ when a bacterial pathogen was regarded as
pathogenic (at least 10E4 or 10E5 cfu/ml) by the attending
microbiologist and reported together with a susceptibility
pattern. A negative culture result and not performing a
urine culture were both considered ‘not positive’.
Department characteristics (Table 3) included 15
variables with information regarding general depart-
ment characteristics, specific routines and already avail-
able stewardship elements. Stewardship elements are
organizational initiatives aimed at improving quality
of antibiotic use [7], e.g. feedback to physicians on anti-
biotic prescription at the individual or department level.
Hospital characteristics (Table 4) included 11 variables
to describe general hospital characteristics and already
available stewardship elements at the hospital level, like
a restrictive policy for certain antibiotics.
Department characteristics were collected using ques-
tionnaires filled in by one internal medicine physician and
one urologist of each participating department (June 2010).
The internal medicine physician also answered the ques-
tionnaire on hospital characteristics.
Analysis
Not every QI was applicable to all included patients,
therefore the sample sizes of the QIs varied. For a QI to
be included, we decided that the minimum sample size
was a mean of 15 patients per department [21].
Missing values in the possible determinants were im-
puted using the MICE technique (Multiple Imputation
Table 2 Patient characteristics. When not all eligible patients
were included (due to missing values) the number of included
patients is indicated in the upper row of the cell
Patients Internal Medicine
(n = 981)
Urology
(n = 983)
Total
(n = 1,964)
Male sex* 381 (40) 753 (77) 1134 (58)
Age in years, median (IQR) 74 (27) 58 (28) 65 (31)
Comorbidity n = 981 n = 981 n = 1962
Any 649 (66) 388 (40) 1037 (53)
Diabetes mellitus 282 (29) 99 (10) 381 (19)
Urological comorbidity
and/or kidney disease
275 (28) 243 (25) 518 (26)
Urinary catheter 168 (17) 104 (11) 272 (14)
Glomerular filtration rate,
MDRD (mL/min/1.73m2),
mean (SD)
n = 974 n = 748 n = 1722
61 (42) 81 (29) 70 (38)
Allergy to (any) antibiotics 63 (6) 66 (7) 129 (7)
Treated at outpatient
department
30 (3) 620 (63) 650 (33)
Admission at night
(7 PM – 7 AM)
n = 634 n = 295 n = 929
213 (34) 67 (23) 280 (30)
Antibiotic therapy
within past 14 days
405 (41) 283 (29) 688 (35)
Febrile UTI n = 980 n = 982 n = 1962
794 (81) 386 (39) 1180 (60)
Positive urine culture n = 979 n = 976 n = 1955
637 (65) 436 (45) 1073 (55)
*Numbers are n (%), unless otherwise indicated
Table 1 Set of Quality Indicators [12]
Quality indicators
1 Perform a urine culture
2A Prescribe empirical therapy in accordance with the national guideline
2B Prescribe empirical therapy in accordance with the local guideline
3 Switch from intravenous to oral therapy within 72 h on the basis of
the clinical condition*
4 Tailor antibiotic treatment on the basis of culture results
5 Use fluoroquinolones selectively (oral therapy, or
in case of anaphylaxis to β-lactam antibiotics)
6A Duration of antibiotic therapy should be at least 10 days
(in accordance with the national guideline)
6B Duration of antibiotic therapy should
be according to the local guideline
7A Treat UTI in men in accordance with the national guideline
7B Treat UTI in men in accordance with the local guideline
8 Replace catheter after initiation of antibiotic treatment
9 Adapt antibiotic dose according to renal function
*Fulfilling the criteria for a safe early switch: haemodynamic stability, no
gastrointestinal problems at 48 h after admission, no Staphylococcus aureus in the
blood culture and the availability of an adequate oral antibiotic, based on culture
result, or the availability of oral equivalent of the i.v. antibiotic [33]
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Using Chained Equations). We generated 5 imputed data
sets, using the mice package in R [22]. For each QI a
unique set of possible determinants was evaluated, be-
cause not all determinants were applicable to every QI,
e.g. outpatients were never involved in a change from
intravenous to oral treatment (see Additional file 1).
Next, the correlation between each pair of determinants
was calculated. If two independent variables were highly
correlated (correlation coefficient >0.6), only one variable
was included in the analysis (see Additional file 1). We
also evaluated the consequences of using more rigor-
ous cut off points (correlation coefficient between two
determinants >0.4) or less rigorous cut off points (co-
efficient >0.8).
Multilevel logistic regression analysis was performed, with
clusters determined by the unique hospital-department
combinations. P-values of ≤0.01 were considered statistically
significant. Odds ratios were reported to describe associa-
tions between determinants and quality indicators (Table 5).
For every indicator, we calculated the explained vari-
ance: the percentage of variance that the determinants
could explain (fit of the models), using a “threshold
model formulation” [23].
Results
Study population
One thousands nine hundred sixty four patients with a
complicated UTI were included. The response rate of
the questionnaires sent to the participating hospitals, to
collect information on department and hospital charac-
teristics, was 100 %. Tables 2, 3 and 4 provide the char-
acteristics of patients, departments and hospitals.
Quality indicators
Figure 1 shows the scores of the 38 departments for each
of the QIs. Due to the minimum sample size for each QI
of a mean of 15 patients per department, three QIs were
excluded from the analyses: ‘Use fluoroquinolones select-
ively’, ‘Replace catheter after initiation of treatment’, and
‘Adapt antibiotic dose according to renal function’. The
median QI performance varied between 31 % (‘Treat UTI
in men according to local guideline’) and 77 % (‘Perform a
urine culture’). Overall, there was a wide inter-department
variation. The box-percentiles plots (involving 90 percent
of all departments) show that outliers could not explain
these wide ranges.
Table 3 Department characteristics
Departments Internal Medicine (n = 19) Urology (n = 19) Total (n = 38)
Number of beds, mean (SD) 67 (22) 18 (9) 43 (30)
% Female physicians, mean (SD) 33 (13) 17 (15) 25 (16)
Teaching hospital department* 17 (89) 12 (63) 29 (76)
Residents working at the department 19 (100) 16 (84) 35 (92)
Microbiological laboratory in the same building as the department 12 (63) 8 (42) 20 (53)
Reporting of a positive urine culture by phone (incidentally or structurally) 0 2 (11) 2 (5)
Structurala education on antibiotics for residents 14 (74) 4 (21) 18 (47)
Structural education on antibiotics for senior staff members 4 (21) 0 4 (11)
Audit and feedback (incidentallyb or structurally)
On antibiotic prescriptionsc, at the department level 2 (11) 8 (42) 10 (26)
On antibiotic prescriptionsc, at the individual level 0 2 (11) 2 (5)
On antibiotic resistance rates of the hospital 9 (47) 12 (63) 21 (55)
Individual advice (of microbiologist/ pharmacist/ infectious diseases
(ID) physician), incidentally or structurally, regarding streamlining
therapy on the basis of blood or urine culture result
16 (84) 16 (84) 32 (84)
Microbiologist and/or ID physician structurally present
at ward rounds discussing antibiotic therapy
6 (32) 0 6 (16)
Quality improvement project concerning antibiotic prescribing in past 3 years 8 (42) 7 (37) 15 (40)
Changes in antibiotic procedures or policies in past 3 yearsd 13 (68) 14 (74) 27 (71)
*Numbers are n (%), unless otherwise indicated
aoccurring repeatedly at fixed moments in time.
boccurring repeatedly but not consequently at fixed moments
cfeedback on the number and classes of antibiotics prescribed by the individual professional
or in the department in a certain time period (not specifically for complicated UTIs)
de.g. culture results became electronically available (while previously on paper), (new) local hospital guideline
for complicated UTIs became available, ID physician joined medical staff (while previously no ID physician)
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Determinants of QI scores
Table 5 shows the statistically significant results of
multilevel regression analyses to explore determinants
for each of the QIs. For also non-significant results see
Additional file 2.
Perform a urine culture
More urine cultures were performed in patients with a
febrile UTI than in patients with a non- febrile UTI. At
departments where residents were working, patients also
had a greater chance to get their urine cultured.
Prescribe empirical therapy in accordance with the
guideline
Adherence to the national guideline for complicated UTIs
was less common in patients with a urinary catheter and
in patients admitted at night. Patients had a better chance
to receive national guideline-adherent therapy in hospitals
with infectious disease (ID) physicians, or with an anti-
biotic formulary available.
Subgroups at risk for receiving empirical therapy not
according to the local hospital guideline were patients
with a urinary catheter, patients who received antibiotic
therapy prior to admission and patients with a non-
febrile UTI. Adherence to the local hospital guideline
was better at departments that organized structural edu-
cation on antibiotics for senior staff members.
Switch from intravenous to oral therapy within 72 hours on
the basis of clinical condition
This switch was less likely to be performed in older pa-
tients and at departments where more female physicians
were working. Providing feedback on antibiotic prescrip-
tion for all infections at the department level was inversely
associated with switching from intravenous to oral therapy
within 72 hours.
Tailor antibiotic treatment on the basis of culture results
At departments where internal medicine physicians or
urologists received feedback about pathogen-directed ther-
apy after determination of the blood or urine culture re-
sults, patients received less culture-guided, tailored therapy.
Duration of antibiotic therapy should be in accordance with
the guideline
Patients with a febrile UTI were more likely to receive
antibiotics for the duration recommended in the national
guideline. Treatment duration was less appropriate in fe-
male patients: in general their treatment durations were
shorter than recommended in the national (10 days) and
local hospital guidelines (varying between 7 -14 days).
Treat UTI in men in accordance with the guideline
Men with a febrile UTI were more likely to be treated in
accordance with the guideline than men with a non-
febrile UTI (definition of this QI see: Method section,
Variables and data collection). Providing feedback on
antibiotic resistance rates of the hospital was positively
associated with adherence to the national guideline.
However, quality improvement projects in the past three
years concerning antibiotic prescribing were inversely
associated with this QI. This negative association was
also shown for the QI ‘Treat every man in accordance
with the local guideline’.
Using more (correlation coefficient > 0.4) or less (cor-
relation coefficient > 0.8) rigorous cut off points for the
maximal correlation between every pair of determinants
hardly changed our results.
The explained variance for each indicator is also shown
in Table 5. Variation between departments in QI perform-
ance scores regarding the QIs ‘Prescribe empirical therapy
in accordance with the (national/local hospital) guideline’
and ‘Switch from intravenous to oral therapy within 72
hours’ could be explained in part by the evaluated patient,
department and hospital characteristics, with explained
variances of 19, 24 and 27 %, respectively.
Table 4 Hospital characteristics
Hospitals n = 19
Presence of infectious diseases (ID) physician* 15 (79)
Teaching hospital for microbiologists 11 (58)
Teaching hospital for ID fellows 4 (21)
Structural ID meetings 13 (68)
Specialism of the chairman of the antibiotic committee
ID physician 3 (16)
Clinical pharmacologist 2 (11)
Microbiologist 13 (68)
No antibiotic committee 1 (5)
Local resistance rates used in determining local guideline 16 (84)
Antibiotic prescribing policies
Antibiotic formulary 17 (89)
Restrictive use of certain antibioticsa 7 (37)
Selective reporting of culture result 11 (58)
Automatic stop-order 1 (5)
Accessibility of local antibiotic guidelines
On paper 2 (11)
Digital 9 (47)
Both 7 (37)
None (no local antibiotic guideline) 1 (5)
*Numbers are n (%), unless otherwise indicated
aPermission of a microbiologist or ID physician required before using it
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Discussion
In this study, we systematically assessed appropriateness
of antibiotic use in patients with a complicated UTI,
using a set of validated quality indicators. A large vari-
ation was demonstrated between departments in per-
formance scores of the QIs. Various determinants, in
particular patient characteristics, influenced the quality
of antibiotic use.
The relatively poor rates of guideline adherence and the
large inter-department variation found in the present study
confirm data from earlier reports in patients with pneumo-
nia and uncomplicated UTIs [20–24]. The variation in QI
performance scores could only be partly explained by the
evaluated patient, department and hospital characteristics,
with explained variances ranging from 11 to 27 %. These
figures are comparable with those found in other studies
exploring determinants of appropriate care [18–20].
As far as we know, this is the first study in which the
entire process of the antibiotic treatment of complicated
UTI is studied. In previous studies, factors influencing
antibiotic use have been evaluated, but complicated UTIs
were not investigated, and most of them focused on a sin-
gle aspect of the antibiotic treatment.
In particular certain patient characteristics influenced
the quality of antibiotic use. Our finding that urine cul-
tures were more likely to be performed in patients with
a febrile UTI are in line with studies in patients with
pneumonia, in which parameters that reflect severity of
disease were positively associated with the collection of
blood cultures [16, 20, 25]. In our study, patients with a
febrile UTI had also better chances to receive the right
antibiotic agent and treatment duration, and men with a
febrile UTI were more likely to be treated in accordance
with the guideline. An explanation for the more appro-
priate treatment of patients with a febrile UTI could be
Table 5 Multivariate associationsa between patient (P), department
(D) and hospital (H) characteristics and QI performance scores, and
explained variance.
QI Odds ratio
(95 % CI)
P
1 Perform a urine culture
P Febrile UTI 1.98 (1.49-2.63) <0.001
D Residents working at department 3.38 (1.60-7.14) 0.001
Explained variance (%) 12.6
2A Prescribe empirical therapy
according to national guideline
P Admission at night 0.61 (0.43-0.86) 0.007
P Urinary catheter 0.15 (0.10-0.22) <0.001
H Presence of infectious
diseases (ID) physician
2.52 (1.27-5.01) 0.008
H Antibiotic formulary 2.98 (1.33-6.67) 0.008
Explained variance (%) 19.4
2B Prescribe empirical therapy
according to local guideline
P Febrile UTI 1.75 (1.23-2.49) 0.002
P Antibiotic therapy
within past 14 days
0.68 (0.52-0.90) 0.007
P Urinary catheter 0.47 (0.31-0.71) <0.001
D Structural education on antibiotics
for senior staff members
10.39 (2.83-38.15) <0.001
Explained variance (%) 23.7
3 Switch from iv to oral therapy within
72 hours on the basis of the
clinical condition
P Older age 0.85 (0.75-0.95)b 0.005
D Feedback on antibiotic prescription
at the department level
0.25 (0.10-0.59) 0.002
D Higher proportion female physicians 0.70 (0.55-0.90)c 0.005
Explained variance (%) 26.5
4 Tailor antibiotic treatment on
the basis of culture results
D Feedback regarding pathogen-directed
therapy on the basis of blood or urine
culture result
0.23 (0.11-0.48) <0.001
Explained variance (%) 11.1
6A Duration of antibiotic therapy
should be at least 10 days
P Febrile UTI 2.22 (1.62-3.05) <0.001
P Female patient 0.44 (0.33-0.58) <0.001
Explained variance (%) 12.3
6B Duration of antibiotic therapy should
be according to local guideline
P Female patient 0.59 (0.44-0.80) <0.001
Explained variance (%) 15.7
7A Treat UTI in men according
to national guideline
P Febrile UTI 2.33 (1.60-3.40) <0.001
Table 5 Multivariate associationsa between patient (P), department
(D) and hospital (H) characteristics and QI performance scores, and
explained variance. (Continued)
D Quality improvement
project in past 3 years
0.46 (0.27-0.77) 0.004
D Feedback on antibiotic resistance
rates of the hospital
2.07 (1.19-3.61) 0.01
Explained variance (%) 17.6
7B Treat UTI in men according
to local guideline
D Quality improvement
project in past 3 years
0.29 (0.13-0.65) 0.003
Explained variance (%) 17.1
aData are presented as Odds Ratios (95 % confidence interval); an Odds Ratio > 1
means a positive association with the QI and an Odds Ratio < 1 means a
negative association.
bOR per 10 years increase in age (per 1 year increase in age: OR 0.98; 95 %
CI: 0.97-1.00).
cOR per 10 % increase in proportion female physicians
(per % increase: OR 0.97; 95 % CI: 0.94-0.99).
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that they are a rather uniform group, and as such more
easily recognized as having a complicated UTI. In con-
trast, patients with a non-febrile UTI are a more diverse
group: male patients, and patients with an abnormality
of the urinary tract or with an immunodeficiency, who
can be mistakenly regarded as having an uncomplicated
UTI. Furthermore, in international guidelines regarding
the diagnosis and treatment of men with cystitis/prosta-
titis and patients with urinary catheter-associated UTIs,
high-quality evidence is lacking and recommendations
are often based on expert opinion [26, 27].
There was a strong negative association between hav-
ing a urinary catheter and prescribing empirical therapy
in accordance with both the national and local hospital
guidelines, which include specific treatment recommen-
dations for these patients. Other patient characteristics
associated with inappropriate antibiotic use were age
(older age: less switching) and gender (females: less ap-
propriate treatment duration). An explanation for the
negative association of female gender of the patient with
receiving the recommended treatment duration could be
that some studies suggested shorter treatment to be ap-
propriate in premenopausal, nonpregnant women with
acute pyelonephritis [28, 29].
Concerning department and hospital characteristics,
including available stewardship elements, the presence
of an ID physician was positively associated with prescrib-
ing empirical therapy in accordance with the national
guideline. This is in line with the growing evidence that ID
physicians play an important role in patient care, infection
control and antibiotic management [30]. Other stewardship
elements associated with more appropriate antibiotic use
were the presence of an antibiotic formulary, feedback on
antibiotic resistance rates of the hospital and structural
education on antibiotics for senior staff members. Surpris-
ingly, a few stewardship elements were inversely associ-
ated with appropriate antibiotic use, e.g. feedback about
pathogen-directed therapy was associated with less culture-
guided antibiotic therapy. A possible explanation for this
paradox is that we asked for feedback on culture results in
general, not specifically for feedback on UTIs. Hypothetic-
ally, if feedback on blood cultures was structurally pro-
vided, but feedback on urine cultures not (or incidentally),
it might have had an inverse effect on tailoring therapy for
UTIs. The association between quality improvement pro-
jects in the past three years and less appropriate treatment
of UTI in men is another example of such a paradox. It is
important to realize that we asked for projects concerning
antibiotic prescribing, not specifically for UTIs or UTIs in
men, so unintended effects (concerning this QI) might have
played a role. Overall, no hospital or departments charac-
teristics, including stewardship elements, were consistently
Fig. 1 Department performance scores on the QIs. Box-percentiles plots show the proportional distribution. Departments are indicated by vertical
black lines ( | ). The box contains 90 percent of all departments. The median and the 30th and 70th percentiles are marked with a vertical blue line
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associated with better performance on the QIs. With the
implementation of antibiotic stewardship programs at a
large scale, our study underlines the need of careful evalu-
ation of the effects of different clearly described stew-
ardship elements, to assess their effect in daily clinical
practice. However, we should be aware that antibiotic
stewardship programs comprise the introduction of a
menu of different interventions [7], whose effect could be
more than the sum of effects of single (available) steward-
ship elements. In addition, we measured QI performance
scores, not clinical endpoints.
The strength of the study is the rigorous and objective
assessment of appropriate antibiotic use, using a system-
atically developed set of guideline-based QIs, describing
the entire process of antibiotic use in complicated UTIs,
from admission to discharge. We earlier demonstrated
that better performance on the total set of QIs was asso-
ciated with a shorter length of hospital stay [31]. The
large sample of 1964 patients from 19 different hospitals
all over the Netherlands contributes to the validity of the
results. Care for UTI patients is performed at the in- and
outpatient departments of internal medicine and ur-
ology. Since patients from both departments were in-
cluded, our findings are largely representative for the
entire UTI population. The study is based on the ac-
curate diagnosis by treating physicians who can be
notoriously inaccurate in diagnosing UTIs [32], how-
ever, the study demonstrates real life application of
the UTI guideline.
Our study has limitations. First, department and hos-
pital characteristics were collected from questionnaires
sent to an internist and a urologist of each participating
hospital. This may have introduced bias, through issues
of social desirability. However, the majority of the ques-
tions concerned basic factual information. Second, charac-
teristics of the individual treating physician, which could
also contribute to variation in appropriate antibiotic use
(e.g. clinical experience, membership of local antibiotic
committee) were not measured, since most patients during
admission were treated by a dynamic team of senior
staff members and residents. A final limitation of the
study was the explorative design used to identify pos-
sible determinants. Owing to this design, associations
can be demonstrated, but causal relationships cannot
be inferred.
Conclusion
A large inter-department variation was demonstrated in
the appropriateness of antibiotic use. In particular patient
characteristics were associated with the risk to receive
less appropriate antibiotic treatment. Some, but not all
antibiotic stewardship elements did translate into bet-
ter QI performance.
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